InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by BROENNIMAN EDWARD G, Director. Officer active across 1 companies, notably Aethlon Medical INC. Aggregated, 7 disclosures have been logged. The latest transaction was disclosed on 31 March 2022 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Declarations7 total
€3,2042,430 shares@ €1.31860.056% mcap6.7% of flow
Common Stock
SEC:0001209191-22-021846:0·
€3,9912,430 shares@ €1.642418.0% of flow
Common Stock
SEC:0001209191-22-000272·
€3,9912,430 shares@ €1.64240.069% mcap8.4% of flow
Common Stock
SEC:0001209191-22-000272:0·
€8,1042,430 shares@ €3.334936.6% of flow
Common Stock
SEC:0001209191-21-058477·
€8,1042,430 shares@ €3.33490.14% mcap17.1% of flow
Common Stock
SEC:0001209191-21-058477:0·
€10,0632,430 shares@ €4.141145.4% of flow
Common Stock
SEC:0001209191-21-044372·
€10,0632,430 shares@ €4.14110.17% mcap21.2% of flow
Common Stock
SEC:0001209191-21-044372:0·
7 of 7 declarations
About BROENNIMAN EDWARD G
Edward G. Broenniman is a Director at Aethlon Medical Inc. In this role, he contributes to the governance of the company and strategic decision-making. Edward brings expertise in the medical and technology sectors, which is essential for guiding Aethlon's policies and practices. His commitment to innovation and ethics is crucial for the sustainable development of the company.
